Middle East & Africa Mid-Size Pharmaceutical Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Prescription and Over-the-Counter), Drug Development Type (In-House and Outsource), Formulation (Tablets and Capsules, Injectables, Sprays, and Other Formulations), and Therapy Class (Cardiovascular Diseases, Pain Management, Diabetes, Cancer, and Other Conditions)
The mid-size pharmaceutical market in the Middle East & Africa is expected to grow from US$ 19,569.41 million in 2022 to US$ 23,913.96 million by 2028; it is estimated to grow at a CAGR of 3.4% from 2022 to 2028.
Pharmaceutical companies are interested in ensuring R&D achieves their intended goal. The number of new drugs approved each year has also increased over the last decade. Efforts are being made to achieve greater effectiveness and efficiency in meeting patients' needs. Recent studies have estimated average R&D costs per new drug are less than US$ 1 billion to over US$ 2 billion per drug. These estimates include the cost of laboratory and clinical trials of successful new drugs and drugs that enter clinical trials but fail or do not go through the laboratory development phase. These top trends transform the pharmaceutical industry and can have short-term and long-term implications. Therefore, the surging focus on R&D drives the growth of the Middle East & Africa mid-size pharmaceutical market.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Middle East & Africa mid-size pharmaceutical market. The Middle East & Africa mid-size pharmaceutical market is expected to grow at a good CAGR during the forecast period.
Middle East & Africa Mid-Size Pharmaceutical Market Revenue and Forecast to 2028 (US$ Million)
Middle East & Africa Mid-Size Pharmaceutical Market Segmentation
The Middle East & Africa mid-size pharmaceutical market is segmented on the basis of type, drug development type, formulation, therapy class, and country.
Based on type, the Middle East & Africa mid-size pharmaceutical market is bifurcated into prescription and over-the-counter. In 2022, the over-the-counter segment accounted for a larger market share. Based on drug development type, the market is bifurcated into in-house and outsource. The outsource segment held a larger market share in 2022. Based on formulation, the Middle east & Africa mid-size pharmaceutical market is segmented into tablets and capsules, injectables, sprays, and other formulations. The tablets & capsules segment held the largest market share in 2022. Based on therapy class, the market is segmented into cardiovascular diseases, pain management, diabetes, cancer, and other conditions. The diabetes segment held the largest market share in 2022. Based on country, the Middle East & Africa mid-size pharmaceutical market is segmented into Saudi Arabia, South Africa, the UAE, and Rest of Middle East & Africa. Saudi Arabia held the largest market share in 2022.
Alexion Pharmaceuticals, Inc.; Bausch Health Companies Inc.; Daiichi Sankyo Company Limited; Endo Pharmaceuticals Inc.; Mallinckrodt; and Sun Pharmaceutical Industries Ltd are among the leading companies operating in the mid-size pharmaceutical market in the region.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa mid-size pharmaceutical market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa mid-size pharmaceutical market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the mid-size pharmaceutical market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution"
- 1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 MEA Mid-Size Pharmaceutical – By Type
- 1.3.2 MEA Mid-Size Pharmaceutical – By Drug Development Type
- 1.3.3 MEA Mid-Size Pharmaceutical – By Formulation
- 1.3.4 MEA Mid-Size Pharmaceutical – By Therapy Area
- 1.3.5 MEA Mid-Size Pharmaceutical – By Country
- 2. Mid-Size Pharmaceutical– Key Takeaways
- 3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
- 4. MEA Mid-Size Pharmaceutical – Market Landscape
- 4.1 Overview
- 4.2 MEA PEST Analysis
- 4.3 Expert Opinion
- 5. Mid-Size Pharmaceutical Market – Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Rising Cases of Chronic Disorders
- 5.1.2 New Product Approval and Launches
- 5.2 Market Restraints
- 5.2.1 High Competition Among Market Players
- 5.3 Market Opportunities
- 5.3.1 Rising Number of Healthcare Start-ups
- 5.4 Future Trends
- 5.4.1 Surging Focus on R&D
- 5.5 Impact Analysis
- 6. Mid-Size Pharmaceutical Market– MEA Analysis
- 6.1 MEA Mid-Size Pharmaceutical Market Revenue Forecast And Analysis
- 7. MEA Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028– by Type
- 7.1 Overview
- 7.2 MEA Mid-Size Pharmaceutical Market Revenue Share, by Type (2022 and 2028)
- 7.3 Prescription
- 7.3.1 Overview
- 7.3.2 Prescription: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
- 7.4 Over-the-Counter (OTC)
- 7.4.1 Overview
- 7.4.2 Over-the-Counter: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
- 8. MEA Mid-Size Pharmaceutical Market Analysis – By Drug Development Type
- 8.1 Overview
- 8.2 MEA Mid-Size Pharmaceutical Market Revenue Share, by Drug Development Type (2022 and 2028)
- 8.3 In-House
- 8.3.1 Overview
- 8.3.2 In-House: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
- 8.4 Outsource
- 8.4.1 Overview
- 8.4.2 Outsource: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
- 9. MEA Mid-Size Pharmaceutical Market – By Formulation
- 9.1 Overview
- 9.2 MEA Mid-Size Pharmaceutical Market, by Formulation, 2022 and 2028 (%)
- 9.3 Tablets and Capsules
- 9.3.1 Overview
- 9.3.2 Tablets and Capsules: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
- 9.4 Injectables
- 9.4.1 Overview
- 9.4.2 Injectables: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
- 9.5 Sprays
- 9.5.1 Overview
- 9.5.2 Sprays: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
- 9.6 Other Formulations
- 9.6.1 Overview
- 9.6.2 Others: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
- 10. MEA Mid-Size Pharmaceutical Market – By Therapy Class
- 10.1 Overview
- 10.2 MEA Mid-Size Pharmaceutical Market, by Therapy Class, 2022 and 2028 (%)
- 10.3 Cardiovascular Diseases
- 10.3.1 Overview
- 10.3.2 Cardiovascular Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
- 10.4 Pain Management
- 10.4.1 Overview
- 10.4.2 Pain Management: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
- 10.5 Diabetes
- 10.5.1 Overview
- 10.5.2 Diabetes: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
- 10.6 Cancer
- 10.6.1 Overview
- 10.6.2 Cancer: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
- 10.7 Other Diseases
- 10.7.1 Overview
- 10.7.2 Other Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
- 11. MEA Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 – Country Analysis
- 11.1 Overview
- 11.1.1 MEA Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Country (%)
- 11.1.1.1 UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
- 11.1.1.1.1 Overview
- 11.1.1.1.2 UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
- 11.1.1.1.3 UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)
- 11.1.1.1.4 UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028, By Drug Development Type (US$ Million)
- 11.1.1.1.5 UAE: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
- 11.1.1.1.6 UAE: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
- 11.1.1.2 Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
- 11.1.1.2.1 Overview
- 11.1.1.2.2 Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
- 11.1.1.2.3 Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)
- 11.1.1.2.4 Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028, By Drug Development Type (US$ Million)
- 11.1.1.2.5 Saudi Arabia: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
- 11.1.1.2.6 Saudi Arabia: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
- 11.1.1.3 South Africa: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
- 11.1.1.3.1 Overview
- 11.1.1.3.2 South Africa Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
- 11.1.1.3.3 South Africa: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)
- 11.1.1.3.4 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Drug Development Type (US$ Million)
- 11.1.1.3.5 South Africa: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
- 11.1.1.3.6 South Africa: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
- 11.1.1.4 Rest of MEA: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
- 11.1.1.4.1 Overview
- 11.1.1.4.2 Rest of MEA: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
- 11.1.1.4.3 Rest of MEA: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)
- 11.1.1.4.4 Rest of MEA: Metabolomics Market Revenue and Forecasts To 2028, By Drug Development Type (US$ Million)
- 11.1.1.4.5 Rest of MEA: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
- 11.1.1.4.6 Rest of MEA: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
- 12. Mid-Size Pharmaceutical Market–Industry Landscape
- 12.1 Overview
- 12.2 Growth Strategies Done by the Companies in the Market, (%)
- 12.3 Organic Developments
- 12.3.1 Overview
- 12.4 Inorganic Developments
- 12.4.1 Overview
- 13. Company Profiles
- 13.1 DAIICHI SANKYO COMPANY LIMITED
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
- 13.2 Bausch Health Companies Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
- 13.3 Sun Pharmaceutical Industries Ltd
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
- 13.4 Alexion Pharmaceuticals, Inc.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
- 13.5 Mallinckrodt
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
- 13.6 Endo Pharmaceuticals Inc.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
- 14. Appendix
- 14.1 About The Insight Partners
- 14.2 Glossary of Terms
- LIST OF TABLES
- Table 1. UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)
- Table 2. UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Drug Development Type (US$ Million)
- Table 3. UAE: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
- Table 4. UAE: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
- Table 5. Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)
- Table 6. Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Drug Development Type (US$ Million)
- Table 7. Saudi Arabia: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
- Table 8. Saudi Arabia: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
- Table 9. South Africa Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)
- Table 10. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Drug Development Type (US$ Million)
- Table 11. South Africa: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
- Table 12. South Africa: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
- Table 13. Rest of MEA: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)
- Table 14. Rest of MEA: Metabolomics Market Revenue and Forecasts to 2028, By Drug Development Type (US$ Million)
- Table 15. Rest of MEA: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
- Table 16. Rest of MEA: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
- Table 17. Organic Developments Done By Companies
- Table 18. Inorganic Developments Done By Companies
- Table 19. Glossary of Terms
- LIST OF FIGURES
- Figure 1. MEA Mid-Size Pharmaceutical Segmentation
- Figure 2. MEA Mid-Size Pharmaceutical Segmentation, By Country
- Figure 3. MEA Mid-Size Pharmaceutical Overview
- Figure 4. Over-the-Counter Segment Held Largest Share by Type in MEA Mid-Size Pharmaceutical Market
- Figure 5. Saudi Arabia is Expected to Show Remarkable Growth During the Forecast Period
- Figure 6. Middle East & Africa: PEST Analysis
- Figure 7. MEA Mid-Size Pharmaceutical Market– Revenue Forecast And Analysis – 2020- 2028
- Figure 8. MEA Mid-Size Pharmaceutical Market Revenue Share, by Type (2022 and 2028)
- Figure 9. MEA Prescription: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 10. MEA Over-the-Counter: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 11. MEA Mid-Size Pharmaceutical Market Revenue Share, by Drug Development Type (2022 and 2028)
- Figure 12. MEA In-House: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 13. MEA Outsource: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 14. MEA Mid-Size Pharmaceutical Market, by Formulation, 2022 and 2028 (%)
- Figure 15. MEA Tablets and Capsules: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 16. MEA Injectables: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 17. MEA Sprays: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 18. MEA Others: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 19. MEA Mid-Size Pharmaceutical Market, by Therapy Class, 2022 and 2028 (%)
- Figure 20. MEA Cardiovascular Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 21. MEA Pain Management: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 22. MEA Diabetes: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 23. MEA Cancer: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 24. MEA Other Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 25. MEA Mid-Size Pharmaceutical Market Revenue Overview, by Country, 2021 (US$ Million)
- Figure 26. MEA Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Country (%)
- Figure 27. UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
- Figure 28. Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
- Figure 29. South Africa: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
- Figure 30. Rest of MEA: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
- Figure 31. Growth Strategies Done by the Companies in the Market, (%)
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook